Impact of Precision Medicine in Oncology Immuno-oncology

被引：0

作者：

Buchbinder, Elizabeth I. ^{[1
,2
,3
,5
]}

Hodi, F. Stephen ^{[1
,2
,3
,4
]}

机构：

[1] Dana Farber Canc Inst, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med, Boston, MA USA

[3] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA

[4] Dana Farber Canc Inst, Ctr Immuno Oncol, Boston, MA USA

[5] 450 Brookline Ave, Boston, MA 02215 USA

来源：

CANCER JOURNAL | 2023年 / 29卷 / 01期

关键词：

CAR-T cell; immune checkpoint inhibition; immunotherapy; cellular therapy; cytokine; TIL therapy; INTERLEUKIN-2 HD IL-2; RENAL-CELL CARCINOMA; METASTATIC MELANOMA; T-CELLS; PD-1; CTLA-4; THERAPY; IMMUNOTHERAPY; IPILIMUMAB; BLOCKADE;

D O I：

10.1097/PPO.0000000000000641

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.

引用

页码：15 / 19

页数：5

共 50 条

[21] Novel Nuclear Medicine Imaging Applications in Immuno-Oncology [J].

Frega, Stefano ;

Dal Maso, Alessandro ;

Pasello, Giulia ;

Cuppari, Lea ;

Bonanno, Laura ;

Conte, PierFranco ;

Evangelista, Laura .

CANCERS, 2020, 12 (05)

[22] Immuno-oncology and interventional oncology: a winning combination. The latest scientific evidence [J].

Lucatelli, P. ;

Iezzi, R. ;

De Rubeis, G. ;

Goldberg, S. N. ;

Bilbao, J., I ;

Sami, A. ;

Akhan, O. ;

Giuliante, F. ;

Pompili, M. ;

Tagliaferri, L. ;

Valentini, V. ;

Gasbarrini, A. ;

Colosimo, C. ;

Bezzi, M. ;

Manfredi, R. .

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (12) :5343-5350

[23] Racing CARs to veterinary immuno-oncology [J].

Cockey, James R. ;

Leifer, Cynthia A. .

FRONTIERS IN VETERINARY SCIENCE, 2023, 10

[24] Primer on Immuno-Oncology and Immune Response [J].

Kannan, Rajni ;

Madden, Kathleen ;

Andrews, Stephanie .

CLINICAL JOURNAL OF ONCOLOGY NURSING, 2014, 18 (03) :311-+

[25] Repurposing Radiation Therapy for Immuno-oncology [J].

Tang, J. ;

Malachowska, B. ;

Wu, X. ;

Guha, C. .

CLINICAL ONCOLOGY, 2021, 33 (11) :683-693

[26] Thematic Issue: Immuno-Oncology and Immunotherapy [J].

Zamyatnin, A. A., Jr. .

BIOCHEMISTRY-MOSCOW, 2019, 84 (07) :693-694

[27] Precision Immuno-Oncology in NSCLC through Gender Equity Lenses [J].

Marks, Jennifer ;

Sridhar, Arthi ;

Ai, Angela ;

Kiel, Lauren ;

Kaufman, Rebekah ;

Abioye, Oyepeju ;

Mantz, Courtney ;

Florez, Narjust .

CANCERS, 2024, 16 (07)

[28] Immuno-Oncology in Cancer Care is a Fantastic Opportunity for Interventional Oncology: IO4IO (Interventional Oncology for Immuno-Oncology) Initiative [J].

de Baere, Thierry ;

Tselikas, Lambros ;

Deschamps, Frederic ;

Soria, Jean Charles ;

Marabelle, Aurelien .

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (06) :825-827

[29] Promises and challenges of immuno-oncology from a clinical perspective [J].

Kunitoh, Hideo M. D. .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (02) :101-102

[30] Biotech and Breakthroughs in Immuno-Oncology [J].

Bockman, Jeffrey M. .

UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (04) :511-521

← 1 2 3 4 5 →